Table 7.
Antifungal Class | Molecular Resistance Mechanism | Phenotype |
---|---|---|
Azoles | cyp51A point mutations | Decreased target enzyme 14α-demethylase affinity for drug |
cyp51A tandem repeat in the promoter region with or without accompanying mutations |
Increases the protein level of expression and alters the docking of azoles conferring resistance | |
Non-cyp51A: Overexpression of ATP binding cassette |
Decrease in intracellular drug concentrations (efflux pump upregulation) | |
Echinocandins | FKS1 mutation dependent-mutations in hotspot regions | BDG synthase enzyme with highly reduced sensitivity to echinocandin drugs |
FKS1 mutation independent-caspofungin mediated alteration of the glucan synthetase lipid microenvironment and off-target effect on mitochondria leading to increased reactive oxygen species | Alters the enzyme drug-binding affinity |